Effect of Different Diets on Isotretinoin Users to Serum Lipid Levels
NCT06250673 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2025-05-01
Summary
This research was planned to prevent secondary hyperlipidemia, which may occur due to isotretinoin used in the treatment of severe acne, with diet. There will be three different groups and followed for 12 weeks. Groups will be; Mediterranean Diet, Low Cholesterol Diet (\<200 mg/day) and the Control Group.
Conditions
- Acne Cystic
- Diet, Healthy
Interventions
- DIETARY_SUPPLEMENT
-
Diet experiment
For the isotretinoin users
Sponsors & Collaborators
-
Okan University
collaborator OTHER -
Igdir University
lead OTHER
Principal Investigators
-
Umut Uyar · Igdir University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-11-01
- Primary Completion
- 2024-02-08
- Completion
- 2024-05-28
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Glyceryl Eicosapentaenoate Based Topic Products as an Irritant-free Cream and Serum for Hydration of Sensitive Skin
NCT06219213 ·Status: TERMINATED ·Phase: NA
-
Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia
NCT07295327 ·Status: RECRUITING ·Phase: NA
-
Effects of Colesevelam HCl On Bile Acid Kinetics
NCT00476710 ·Status: COMPLETED
-
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
NCT01236365 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of a Mixture of Allium Extracts on LDL Cholesterol Levels Volunteers With Elevated LDL Cholesterol Levels
NCT04646382 ·Status: COMPLETED ·Phase: NA
-
LIFESTAT - Living With Statins, a Cross Sectional Study
NCT02250677 ·Status: COMPLETED
-
LDL-cholesterol Lowering Effect of a New Dietary Supplement
NCT03425630 ·Status: COMPLETED ·Phase: NA
-
Dyslipidemia Study Investigating The Increase In "Good Cholesterol"
NCT00169559 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
NCT04314167 ·Status: TERMINATED ·Phase: NA
-
Observation of Blood Lipid Outcomes in Lipid Clinic
NCT04220164 ·Status: RECRUITING
-
Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline
NCT00901823 ·Status: WITHDRAWN ·Phase: PHASE1
-
Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Patients With Familial Hypercholesterolemia
NCT05695937 ·Status: COMPLETED ·Phase: NA
-
Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride
NCT02263547 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia
NCT00532558 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of Fenofibrate and Niacin in Patients With Hypertriglyceridemia and Low High-Density Lipoprotein (HDL)-Cholesterol
NCT01122355 ·Status: COMPLETED ·Phase: PHASE4
-
Genetic Influences on Statin Blood Concentrations in African Americans
NCT01569867 ·Status: COMPLETED
-
Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol
NCT00143663 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia
NCT00865228 ·Status: TERMINATED ·Phase: PHASE2
-
Resveratrol and Serum Apo A-I
NCT01364961 ·Status: COMPLETED ·Phase: NA
-
Assessment of Different Equations to Accurately Calculate LDL Cholesterol
NCT05598216 ·Status: ACTIVE_NOT_RECRUITING
-
A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia
NCT02087917 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Mediterranean Diet in Dyslipidemic Patients
NCT04486664 ·Status: UNKNOWN ·Phase: NA
-
The Pharmacokinetic Study of Red Yeast Rice Capsule Compared to Lovastatin Tablet in Healthy Subjects
NCT01527669 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia
NCT07229937 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Test GSK256073 in Patients With Dyslipidemia
NCT00903617 ·Status: COMPLETED ·Phase: PHASE2